Wine, resveratrol and health: A review

Natural Product Communications

Volumn 4, Issue 5, 2009, Pages 635-658

  Guerrero, Raúl F ^a   García Parrilla, Maria C ^b   Puertas, Belén ^a   Cantos Villar, Emma ^a  

^a IFAPA CENTRO EL TORUÑO   (Spain)

^b Univ de Sevilla Avda   (Spain)

Author keywords

Anticarcinogenic; Cardioprotective; Health; Mediterranean diet; Resveratrol; Wine

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTHOCYANIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASTRINGIN; CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; CATECHIN; COUMARIC ACID; DELTA VINIFERIN; ELLAGIC ACID; FLAVAN 3 OL; FLAVONOL DERIVATIVE; GRAPE SEED EXTRACT; HESPERIDIN; HOPEAPHENOL; PICEATANNOL; PICEID; POLYPHENOL DERIVATIVE; PROCYANIDIN; PROCYANIDIN DERIVATIVE; PTEROSTILBENE; QUERCETIN; RESVERATROL; STILBENE DERIVATIVE; TYROSOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINIFERIN;

ABSENCE OF SIDE EFFECTS; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BLADDER CANCER; BRAIN DAMAGE; BREAST CANCER; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLORECTAL CANCER; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG URINE LEVEL; ESOPHAGUS CANCER; ESTROGEN THERAPY; HEALTH; HEART INFARCTION; HEART PROTECTION; HUMAN; LEUKEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER CANCER; LIVER PROTECTION; LUNG CANCER; LUNG CARCINOMA; MAXIMUM PLASMA CONCENTRATION; MEDITERRANEAN DIET; MELANOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PARKINSON DISEASE; POSTMENOPAUSE OSTEOPOROSIS; PROSTATE CANCER; RED WINE; REVIEW; RISK REDUCTION; SKIN TUMOR; STOMACH CANCER; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION INHIBITION; THYROID CANCER; VASODILATATION; WINE;

EID: 69549117663     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0900400503     Document Type: Review

References (240)

1. Key A. (1980) Seven countries: a multivariable analysis of death and coronary heart disease. Harvard University Press, Cambridge, UK.
2. Renaud S, De Lorgeril M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 339, 1523-1526.
3. De Lorgeril M, Salen P, Caillat-Vallet E, Hanauer MT, Barthelemy JC, Mamelle N. (1997) Control of bias in dietary trial to prevent coronary recurrences: The Lyon Diet Heart Study. European Journal of Clinical Nutrition, 51, 116-122. (Pubitemid 27081308)
4. De Lorgeril M, Salen P, Martin JL, Monjaud I, Boucher P, Mamelle N. (1998) Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Archives of International Medicine, 158, 1181-1187. (Pubitemid 28252481)
5. De Lorgeril M, Salen P, Martin JL, Boucher F, Paillard F, de Leiris J. (2002) Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. Circulation, 106, 1465-1469.
6. Lairon, D. (2007) Intervention studies on Mediterranean diet and cardiovascular risk. Molecular Nutrition & Food Research, 51, 1209-1214. (Pubitemid 350013168)
7. Trichopoulou A. (2004) Traditional Mediterranean diet and longevity in the elderly: a review. Public Health Nutrition, 7, 943-947.
8. Skoumas J, Pitsavos C, Panagiotakos DB, Chrysohoou C, Zeimbekis A, Papaioannou I, Toutouza M, Toutouzas P, Stefanadis C. (2003) Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA study. Lipids in Health and Disease, 12, 2-3.
9. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. (2008) Adherence to Mediterranean diet and health status: meta-analysis. British Medical Journal, 337, 1344-1351.
10. Carluccio MA, Siculella L, Ancora MA, Massaro M, Scoditti E, Storelli C, Visioli F, Distante A, de Caterina R. (2003) Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arteriosclerosis Thrombosis, and Vascular Biology, 23, 622-629.
11. Pitsavos C, Panagiotakos DB, Chrysohoou C, Kokkinos PF, Skoumas J, Papaioannou I, Stefanadis C, Toutouzas P (2002) The effect of the combination of Mediterranean diet and leisure time physical activity on the risk of developing acute coronary syndromes, in hypertensive subjects. Journal of Human Hypertension, 16, 517-524.
12. Boyle P, Ferlay J. (2005) Mortality and survival in breast and colorectal cancer. Nature Clinical Practice. Oncology, 2, 424-425.
13. La Vecchia C, Bosetti C. (2006) Diet and cancer risk in Mediterranean countries: open issues. Public Health Nutrition, 9, 1077-1082.
14. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. (2003) Adherence to a Mediterranean diet and survival in a Greek population. The New England Journal of Medicine, 348, 2599-2608.
15. Willett WC, Sacks F, Trichopoulou A, Drescher G. Ferro-Luzzi A, Helsing E, Trichopoulos D. (1995) Mediterranean diet pyramid: a cultural model for healthy eating. The American Journal of Clinical Nutrition, 61(6 Suppl), 1402S-1406S.
16. Avellone G, Di Garbo V, Campisi D, De Simone R, Raneli G, Scaglione R, Licata G. (2006) Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. European Journal of Clinical Nutrition, 60, 41-47. (Pubitemid 43731073)
17. Leighton F, Cuevas A, Guasch V, Perez DD, Strobel P, San Martin A, Urzua U, Diez MS, Foncea R Castillo O, Mizon C, Espinoza MA, Urquiaga I, Rozowski J, Maiz A, Germain A. (1999) Plasma polyphenols and antioxidants, oxidative DNA damage, and endothelial function in a diet and wine intervention study in humans. Drugs under Experimental and Clinical Research, 25, 133-141.
18. Mezzano D, Leighton F, Martinez C, Marshall G, Cuevas A, Castillo O, Panes O, Munoz B, Perez DD, Mizon C, Rozowski J, San Martin A, Pereira J. (2001) Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. European Journal of Clinical Nutrition, 55, 444-451.
19. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willett WC. (1995) Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. American Journal of Epidemiology, 141, 1117-1127.
20. Marfella R, Cacciapuoti F, Siniscalchi M, Sasso FC, Marchese F, Cinone F, Musacchio E, Marfella MA, Ruggiero L, Chiorazzo G, Liberti D, Chiorazzo G, Nicoletti GF, Saron C, D'Andrea F, Ammendola C, Verza M, Coppola L. (2006) Effect of moderate red wine intakes on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus. Diabetic Medicine, 23, 974-981.
21. Briggs NC, Levine RS, Bobo LD, Haliburton WP, Brann EA, Hennekens CH. (2002) Wine drinking and risk of non- Hodgkin's lymphoma among men in the United States: a population-based case-control study. American Journal of Epidemiology, 156, 454-462.
22. Platz EA, Leitzmann MF, Rimm EB, Willett WC, Giovannucci E. (2004) Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study. American Journal of Epidemiology, 159, 444-453.
23. Schoonen WM, Salinas CA, Kiemeney LA, Stanford JL. (2005) Alcohol consumption and risk of prostate cancer in middle-aged men. International Journal of Cancer, 113, 133-140.
24. Schurman AG, Goldbohm RA, Van den Brandt PA. (1999) A prospective cohort study on consumption of alcoholic beverages in relation to prostate cancer incidence (The Netherlands). Cancer Causes Control, 10, 597-605.
25. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, Rotterdam H, West AB, Dubrow R, Stanford JL, Mayne ST, Farrow DC, Niwa S, Blot WJ, Fraumeni JFJr. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. Journal of the National Cancer Institute, 89, 1277-1284.
26. Bessaoud F, Daures JP. (2008) Patterns of alcohol (especially wine) consumption and breast cancer risk: a case -control study among a population in Southern France. Annals of Epidemiology, 18, 467-475.
27. Sutcliffe S, Giovannucci E, Leitzmann MF, Rimm EB, Stampfer MJ, Willett WC, Platz EA. (2007) A prospective cohort study of red wine consumption and risk of prostate cancer. International Journal of Cancer, 120, 1529-1535.
28. Longnecker MP, Orza MJ, Adams ME, Vioque J, Chalmers TC. (1990) A meta-analysis of alcoholic beverage consumption in relation to risk of colorectal cancer. Cancer Causes Control, 1, 59-68.
29. Lugasi A, Hovari J. (2003) Antioxidant properties of commercial alcoholic and nonalcoholic beverages. Nahrung, 47, 79-86.
30. Thirunavukkarasu M, Penumathsa SV, Samuel SM, Akita Y, Zhan L, Bertelli AA, Maulik G, Maulik N. (2008) White wine induced cardioprotection against ischemia-reperfusion injury is mediated by life extending Akt/FOXO3a/NFkappaB survival pathway. Journal of Agricultural and Food Chemistry, 56, 6733-6739.
31. Perez DD, Strobel P, Foncea R, Diez M, Soledad-Vez L, Urquiaga I, Castillo O, Cuevas A, San Martin A, Leighton F. (2002) Wine, diet, antioxidant defences, and oxidative damage. Annals of the New York Academy of Sciences, 957(Alcohol and Wine in Health and Disease), 136-145.
32. Eng ET, Ye JJ, Williams D, Phung S, Moore RE, Young MK, Ugis G, Braunstein G, Chen, S. (2003) Suppression of estrogen biosynthesis by procyanidin dimmers in red wine and grape seeds. Cancer Research, 63, 8516-8522.
33. Visioli F, Grande S, Bogani P, Galli C. (2004) The role of antioxidants in the mediterranean diets: focus on cancer. European Journal of Cancer Prevention: the official journal of the European Cancer Prevention Organisation (ECP), 13, 337-343.
34. Burns J, Crozier A, Lean MEJ. (2001) Alcohol consumption and mortality: is wine different from other alcoholic beverages? Nutrition, Metabolism and Cardiovascular Diseases, 11, 249-258.
35. Longnecker MP, Enger SM. (1996) Epidemiologic data on alcoholic beverage consumption and risk of cancer. Clinica Chimica Acta; International Journal of Clinical Chemistry, 246, 121-141.
36. Boursi B, Arber, N. (2007) Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Current Pharmaceutical Design, 13, 2274-2282.
37. McEligot AJ, Largent J, Ziogas A, Peel D, Anton-Culver H. (2006) Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer. Nutrition and Cancer, 55, 132-140.
38. Seitz HK, Becker P. (2007) Alcohol metabolism and cancer risk. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 30, 38-41, 44-47.
39. Gronbaek M, Becker U, Johansen D, Gottschau A, Schnohr P, Hein HO, Jenesen G, Sorensen, TIA. (2000) Type of alcohol consumed and mortality from all causes, coronary heart disease and cancer. Annals Internal Medicine, 133, 411-419.
40. Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. (2000) Alcohol and coronary heart disease: a meta-analysis. Addiction, 95, 1505-1523.
41. Klatsky AL. (2001) Should patients with heart disease drink alcohol? Journal of the American Association, 285, 2004-2006.
42. Hines LM, Stampfer MJ, Ma J, Gaziano JM, Ridker PM, Hankinson SE, Sacks F, Rimm EB, Hunter DJ. (2001) Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. New England Journal of Medicine, 344, 549-555.
43. Mukamal KJ, Kronmal RA, Mittleman MA, O'Leary DH, Polak JF, Cushman MS, David S. (2003) Alcohol Consumption and Carotid Atherosclerosis in Older Adults. The cardiovascular health study. Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 2252-2259.
44. Gaziano, JM. (1999) Do antioxidants protect against cardiovascular disease? Preventive Cardiology, 2, 59-66.
45. Sacco RL. (1999) Secondary prevention of ischemic stroke: A 1998 US perspective. Cerebrovascular Diseases (Basel, Switzerland), 9(Suppl 3), 37-44.
46. Di Castelnuovo A, Rotondo S, Iacovierllo L, Donati MB, De Gaetano G. (2002) Metaanalysis of wine and beer consumption in relation to vascular risk. Circulation, 195, 2836-2844.
47. Estruch R. (2000) Wine and cardiovascular disease. Food Research International, 33, 219-226.
48. Rodríguez-Artalejo F, Guallar-Castillon P, Banegas JR, de Andres-Manzano B, Del Rey-Calero J. (1998) Consumption of fruit and wine and the decline in cerebrovascular disease mortality in Spain (1975-1993). Stroke, 29, 1556-1561.
49. Blanco-Colio LM, Valderrama M, Alvarez-Sala LA, Bustos C, Ortego M, Hernández-Presa MA, Cancelas P, Gomez-Gerique J, Millan J, Egido J. (2000) Red wine prevents nuclear factor κβ activation in peripheral blood mononuclear cells of healthy volunteers during postprandrial lipemia. Circulation, 102, 1020-1026.
50. Corder R, Douthwaite JA, Lees DM, Khan NQ, Dos Santos ACV, Wood EG, Carier MJ. (2001) Endothelin-1 synthesis reduced by red wine. Nature, 414, 863-864.
51. Al-Awwadi NA, Bornet A, Azay J, Araiz C, Delbosc S, Cristol JP, Linck N, Cros G, Teissedre, PL, (2004) Red wine polyphenols alone or in association with ethanol prevent hypertension, aardiac hypertrophy, and production of reactive oxygen species in the insulin-resistant fructose-fed rat. Journal of Agricultural and Food Chemistry, 52, 5593-5597.
52. Clifford AJ, Ebeler SE, Ebeler JD, Bills ND, Hinrichs SH, Teissedre PL, Waterhouse AL. (1996) Delayed tumor onset in transgenic mice fed an amino acid-based diet supplemented with red wine solids. American Journal of Clinical Nutrition, 64, 748-756.
53. Downey MO, Dokoozlian NK, Krstic MP. (2006) Cultural practice and environmental impacts on the flavonoid composition of grapes and wine: a review of recent research. American Journal of Enology and Viticulture, 57, 257-268.
54. Mazza G. (1995) Anthocyanins in grapes and grapes products. Critical Reviews in Food Science, 35, 341-371.
55. Waterhouse AL. (2002) Wine phenolics. Annals of the New York Academy of Sciences, 957, 21-36.
56. Zafrilla P, Morillas J, Mulero J, Cayuela JM, Martinez-Cacha A, Pardo F, Lopez-Nicolas JM. (2003) Changes during storage in conventional and ecological wine: phenolic content and antioxidant activity. Journal of Agricultural and Food Chemistry, 51, 4694-4700.
57. Carando S, Teissedre PL, Waffo-Teguo P, Cabanis JC, Deffieux G, Merillon JM. (1999) High-performance liquid chromatography coupled with fluorescence detection for the determination of trans-astringin in wine. Journal of Chromatography A, 849, 617-620.
58. Chamkha M, Cathala B, Cheynier V, Douillard R. (2003) Phenolic composition of champagnes from chardonnay and pinot noir vintages. Journal of Agricultural and Food Chemistry, 51, 3179-3184.
59. Monagas M, Bartolome B, Gomez-Cordoves C. (2005) Updated knowledge about the presence of phenolic compounds in wine. Critical Reviews in Food Science and Nutrition, 45, 85-118.
60. Pour Nikfardjam MS, Pickering GJ. (2008) Influence of variety and commercial yeast preparation on red wine made from autochthonous Hungarian and Canadian grapes. Part I: phenolic composition. European Food Research and Technology, 227, 1077-1083.
61. Dell'Agli M, Busciala A, Bosisio E. (2004) Vascular effects of wine polyphenols. Cardiovascular Research, 63, 593-602.
62. Cartron E, Fouret G, Carbonneau MA, Lauret C, Michel F, Monnier L, Descomps B, Leger CL. (2003) Red-wine beneficial longterm effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine-description of two O-methylated derivatives of gallic acid in humans. Free Radical Research, 37, 1021-1035.
63. Ursini F, Sevanian A. (2002) Wine polyphenols and optimal nutrition. Annals of the New York Academy of Sciences, 957, 200-209.
64. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, Schini-Kerth VB. (2004) Vascular protection by dietary polyphenols. European Journal of Pharmacology, 500, 299-313.
65. He S, Sun C, Pan Y. (2008) Red wine polyphenols for cancer prevention. International Journal of Molecular Sciences, 9, 842-853.
66. Pedersen A, Johansen C, Gronbaek M. (2003) Relations between amount and type of alcohol and colon and rectal cancer in a Danish population based cohort study. Gut, 52, 861-867.
67. Dolara P, Luceri C, De Filippo C, Femia AP, Giovannelli L, Caderni G, Cecchini C, Silvi S, Orpianesi C, Cresci A. (2005) Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutation Research, 591, 237-246.
68. Nielsen IL, Chee WS, Poulsen L, Offord-Cavin E, Rasmussen SE, Frederiksen H, Enslen M, Barron D, Horcajada MN, Williamson G. (2006) Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. Journal of Nutrition, 136, 404-408.
69. Scholz S, Williamson G. (2007) Interactions affecting the bioavailability of dietary polyphenols in vivo. International Journal for Vitamin and Nutrition Research, 77, 224-235.
70. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition, 81(1 Suppl), 230S-242S.
71. McGhie TK, Walton MC. (2007) The bioavailability and absorption of anthocyanins: towards a better understanding. Molecular Nutrition & Food Research, 51, 702-713.
72. Boots AW, Haenen GRMM, Bast A. (2008) Health effects of quercetin: From antioxidant to nutraceutical. European Journal of Pharmacology, 585, 325-337.
73. Duarte J, Perez-Palencia R, Vargas F, Ocete MA, Perez-Vizcaino F, Zarzuelo A, Tamargo J. (2001) Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. British Journal of Pharmacology, 133, 117-124. (Pubitemid 32500458)
74. Duarte J, Jimenez R, O'Valle F, Galisteo M, Perez-Palencia R, Vargas F, Perez-Vizcaino F, Zarzuelo A, Tamargo J. (2002) Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. Journal of Hypertension, 20, 1843-1854.
75. Okamoto T. (2005) Safety of quercetin for clinical application (review). International Journal of Molecular Medicine, 16, 275-278.
76. McAnlis GT, McEneny J, Pearce J, Young IS. (1999) Absorption and antioxidant effects of quercetin from onions, in man. European Journal of Clinical Nutrition, 53, 92-96.
77. Aron PM, Kennedy JA. (2008) Flavan-3-ols: nature, occurrence and biological activity. Molecular Nutrition & Food Research, 52, 79-104.
78. Ottaviani JI, Actis-Goretta L, Villordo JJ, Fraga CG. (2006) Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition. Biochimie, 88, 359-365.
79. Lowry JB, McSweeney CS, Palmer B. (1996) Changing perceptions of the effect of plant phenolics on nutrient supply in the ruminant. Australian Journal of Agricultural Research, 47, 829-842.
80. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A, Aviram M. (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 2744-2752.
81. Ruidavets JB, Teissedre PL, Ferrieres J, Carando S, Bougard G, Cabanis JC. (2000) Catechin in the Mediterranean diet: vegetable, fruit or wine? Atherosclerosis, 153, 107-117.
82. Williamson G, Manach C. (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition, 81(1S), 243S-255S.
83. Luceri C, Giannini L, Lodovici M, Antonucci E, Abbate R, Masini E, Dolara P. (2007) p-Coumaric acid, a common dietary phenol, inhibits platelet activity in vitro and in vivo. British Journal of Nutrition, 97, 458-463.
84. Tomera JF. (1999) Current knowledge of the health benefits and disadvantages of wine consumption. Trends in Food Science & Technology, 10, 129-138.
85. Covas MI, Miro-Casas E, Fito M, Farre-Albadalejo M, Gimeno E, Marrugat J, De La Torre R. (2003) Bioavailability of tyrosol, an antioxidant phenolic compound present in wine and olive oil, in humans. Drug Under Experimental and Clinical Research, 29, 203-206.
86. Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G, Caruso D. (2000) Olive oil phenolics are dose-dependently absorbed in humans. FEBS Letters, 468, 159-160.
87. Norata GD, Marchesi P, Passamonti S, Pirillo A, Violi F, Catapano AL. (2007) Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis, 191, 265-271.
88. Pignatelli P, Ghiselli A, Buchetti B, Carnevale R, Natella F, Germano G, Fimognari F, Di Santo S, Lenti L, Violi F. (2006) Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis, 188, 77-83. (Pubitemid 44142538)
89. Takaoka MJ. (1940) Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.). Journal of the Faculty of Science, Hokkaido Imperial University, 3, 1-16.
90. Langcake P, Pryce RJ. (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiological Plant Pathology, 9, 77-86.
91. Siemann EH, Creasy LL. (1992) Concentration of the phytoalexin resveratrol in wine. American Journal of Enology and Viticulture, 43, 49-52.
92. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, Estrela JM. (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radical Biology and Medicine, 33, 387-398. (Pubitemid 34786278)
93. Jang MS, Cai EN, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220. (Pubitemid 127696281)
94. Bradamante S, Barenghi L, Villa A. (2004) Cardiovascular protective effects of resveratrol. Cardiovascuar Drug Review, 22, 169-188.
95. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191-196. (Pubitemid 37150899)
96. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Current Biology, 16, 296-300. (Pubitemid 43190229)
97. Harborne JB. The comparative biochemistry of phytoalexins induction in plants. (1999) Biochemical Systematics and Ecology, 27, 335-367.
98. Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J, Van Breemen RB. (2003) Resveratrol in raw and baked blueberries and bilberries. Journal of Agricultural and Food Chemistry, 51, 5867-5870.
99. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. (2002) Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. International Journal of Molecular Medicine, 9, 77-79.
100. Burns J, Gardner PT, Yokota T, Ashihara H, Lean ME, Crozier A. (2002) Plant foods and herbal sources of resveratrol. Journal of Agricultural and Food Chemistry, 50, 3337-3340. (Pubitemid 34533643)
101. Tokusoglu O, Unal MK, Yemis F. (2005) Determination of the phytoalexin resveratrol (3,5,4′-trihydroxystilbene) in peanuts and pistachios by high performance liquid chromatographic diode array (HPLC-DAD) and gas chromatography-mass spectrometry (GC-MS). Journal of Agricultural and Food Chemistry, 53, 5003-5009. (Pubitemid 40937627)
102. Counet C, Callemien D, Collin S. (2006) Chocolate and cocoa: new sources of trans-resveratrol and trans-piceid. Food Chemistry, 98, 649-657.
103. Cantos E, Espín JC, Tomás-Barberán FA. (2002) Postharvest stilbene-enrichment of red and white table grape varieties using UVC irradiation pulses. Journal of Agricultural and Food Chemistry, 50, 6322-6329. (Pubitemid 35216734)
104. Romero-Pérez AI, Ibern-Goméz M, Lamuela-Raventós RM, de la Torre-Boronat MC. (1999) Piceid, the major resveratrol derivative in grape juices. Journal of Agricultural and Food Chemistry, 47, 1533-1536.
105. Romero-Pérez A, Lamuela-Raventós RM, Waterhouse AL, de la Torre-Boronat MC. (1996) Levels of cis- and trans-resveratrol and their glucosides in white and rosé Vitis vinifera wines from Spain. Journal of Agricultural and Food Chemistry, 44, 2124-2128.
106. Lamuela-Raventós RM, Romero-Pérez AI, Waterhouse AL, De la Torre-Boronat MC. (1995) Direct HPLC analysis of cis- and trans- resveratrol and piceid isomers in Spanish red Vitis vinifera wines. Journal of Agricultural and Food Chemistry, 43, 281-283.
107. Landrault N, Larronde F, Delaunay JC, Castagnino C, Vercauteren J, Merillon JM, Gasc F, Cros G, Teissedre PL. (2002) Levels of stilbene oligomers and astilbin in French wines and grapes during noble rot development. Journal of Agricultural and Food Chemistry, 50, 2046-2052. (Pubitemid 34260009)
108. Stervbo U, Vang O, Bonnesen C. (2006) Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Proliferation, 39, 479-493. (Pubitemid 44760200)
109. Bavaresco L. (2003) Role of viticultural factors on stilbene concentrations of grapes and wine. Drugs under experimental and clinical research, 29, 181-187.
110. Soleas GJ, Goldberg DM, Karumanchiri A, Diamandis EP, Ng E. (1995) Influences of viticultural and enological factors on changes in cis- and trans-resveratrol in commercial wines. Journal of Wine Research, 6, 107-121.
111. Vrhovsek U, Wendelin S, Eder R. (1997) Effects of various vinification techniques on the concentration of cis- and transresveratrol and resveratrol glucoside isomers in wine. American Journal of Enology and Viticulture, 48, 214-219. (Pubitemid 27266582)
112. Frémont L. (2000) Biological effects of resveratrol. Life Science, 66, 663-673.
113. Stervbo U, Vang O, Bonnesen C. (2007) A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chemistry, 101, 449-457. (Pubitemid 44333178)
114. Goldberg DM, Ng, E, Karumanchiri A, Diamandis EP, Soleas GJ. (1996) Resveratrol glucosides are important components of commercial wines. American Journal of Enology and Viticulture, 47, 415-420. (Pubitemid 27027674)
115. Roldán A, Palacios V, Caro I, Pérez L. (2003) Resveratrol content of Palomino Fino grapes: influence of vintage and fungal infection. Journal of Agricultural and Food Chemistry, 51, 1464-1468.
116. Soleas GJ, Diamandis EP, Goldberg DM. (1997) Wine as a biological fluid: history, production, and role in disease prevention. Journal of Clinical Laboratory Analysis, 11, 287-313.
117. Iriti M, Rossoni M, Borgo M, Faoro F. (2004) Benzothiadiazole enhances resveratrol and anthocyanin biosynthesis in grapevine, meanwhile improving resistance to botrytis cinerea. Journal of Agricultural and Food Chemistry, 52, 4406-4413.
118. Romanazzi G, Gabler FM, Smilanick JL. (2006) Preharvest chitosan and postharvest UV irradiation treatments suppress gray mold of table grapes. Plant Disease, 90, 445-450.
119. Cantos E, Tomás-Barberán FA, Martínez A, Espín JC. (2003) Differential stilbene induction susceptibility of seven red wine grape varieties upon postharvest UV-C irradiation. European Food Research and Technology, 217, 253-258.
120. González-Candelas L, Gil JV, Lamuela-Raventós RM, Ramón D. (2000) The use of transgenic yeast expressing a gene encoding a glycosyl-hydrolase as a tool to increase resveratrol content in wine. International Journal of Food Microbiology, 59, 179-183.
121. Becker JVW, Armstrong GO, Van der Merwe MJ, Lambrechts MG, Vivier MA, Pretorious IS. (2003) Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Research, 4, 79-85.
122. Zhang Y, Li SZ, Li J, Pan X, Cahoon RE, Jaworski JG, Wang X, Jez JM, Chen F, Yu O. (2006) Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells. Journal of the American Chemical Society, 128, 13030-13031.
123. Poutaraud A, Latouche G, Martins S, Meyer S, Merdinoglu D, Cerovic ZG. (2007) Fast and local assestment of stilbene content in grapevine leaf by in vivo fluorometry. Journal of Agricultural and Food Chemistry, 55, 4913-4920.
124. Buiarelli F, Coccioli F, Jasionowska R, Merolle M, Terracciano A. (2007) Analysis of some stilbenes in Italian wines by liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 21, 2955-2964.
125. Güebailia HA, Chira K, Richard T, Mabrouk T, Furiga A, Vitrac X, Monti JP, Delaunay JC, Merillon JM. (2006) Hopeaphenol: the first resveratrol tetramer in wines from north Africa. Journal of Agricultural and Food Chemistry, 54, 9559-9564.
126. Ribeiro de Lima MT, Waffo-Teguo P, Teissedre PL, Pujolas A, Vercauteren J, Cabanis JC, Mérillon JM. (1999) Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis- and trans-resveratrol) in Portuguese wines. Journal of Agricultural and Food Chemistry, 47, 2666-2670.
127. Vitrac X, Bornet A, Vanderlinde R, Valls J, Richard T, Delauna, JC, Merillon JM, Teissedre PL. (2005) Determination of stilbenes (δ-viniferin, trans-astringin, trans-piceid, cis- and trans-resveratrol, ε-viniferin) in Brazilian wines. Journal of Agricultural and Food Chemistry, 53, 5664-5669.
128. Pezet R, Gindro K, Viret O, Spring JL. (2004) Glycosylation and oxidative dimerization of resveratrol are respectively associated to sensitivity and resistance of grapevine cultivars to downy mildew. Physiological and Molecular Plant Pathology, 65, 297-303.
129. Vitrac X, Monti JP, Vercaueren J, Deffieux G, Mérillon JM. (2002) Direct liquid chromatographic analysis of resveratrol derivates and flavonols in wines with absorbance and fluorescence detection. Analytica Chimica Acta, 458, 103-110.
130. Waffo-Teguo P, Fauconneau B, Deffieeux C, Huguet F, Vercauteren J, Merillon JM. (1998) Isolation, identification and antioxidant active of three stilbene glycosides newly extracted from Vitis vinifera cell cultures. Journal of Natural Products, 61, 655-657.
131. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. (1982) Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chemical and Pharmaceutical Bulletin, 30, 1766-1770.
132. Riviere C, Richard T, Quentin L, Krisa S, Merillon JM, Monti JP. (2007) Inhibitory activity of stilbenes on Alzheimer's β- amyloid fibrils in vitro. Bioorganic & Medicinal Chemistry, 15, 1160-1167. (Pubitemid 44880692)
133. Meng X, Maliakal P, Lu H, Lee MJ, Yang CS. (2004) Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. Journal of Agricultural and Food Chemistry, 52, 935-942.
134. Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R. (2005) Bioavailability of transresveratrol from red wine in humans. Molecular Nutrition and Food Research, 49, 495-504. (Pubitemid 40780396)
135. Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK. (2002) The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. British Journal of Pharmacology, 135, 1627-1633.
136. Murias M, Jaeger W, Handler N, Erker T, Horvath Z, Szekeres T, Nohl H, Gille L. (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochemical Pharmacology, 69, 903-912. (Pubitemid 40312708)
137. Kuo PL, Hsu YL. (2008) The grape and wine constituent piceatannol inhibits proliferation of human bladder cancer cells via blocking cell cycle progression and inducing Fas/membrane bound Fas ligand-mediated apoptotic pathway. Molecular Nutrition & Food Research, 52, 408-418.
138. Piver B, Fer M, Vitral X, Mérillon JM, Dreano Y, Berthou F, Lucas D. (2004) Involment of cytochrome P450 1A2 in the transformation of trans-resveratrol in human liver microsomes. Biochememical Pharmacology, 68, 773-782. (Pubitemid 38953459)
139. Hung LM, Chen JK, Lee RS, Liang HC, Su MJ. (2001) Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radical Biology & Medicine, 30, 877-883. (Pubitemid 32289265)
140. Fu ZD, Cao Y, Wang KF, Xu SF, Han R. (2004) Chemopreventive effect of resveratrol to cancer. Ai Zheng, 23, 869-873.
141. Schoeppner A, Kindl H. (1979) Stilbene synthase (pinosylvin synthase) and its induction by ultraviolet light. FEBS Letters, 108, 349-352.
142. Adrian M, Jeandet P, Douillet-Breuil AC, Tesson L, Bessis R. (2000) Stilbene content of mature Vitis vinifera berries in response to UV-C elicitation. Journal of Agricultural and Food Chemistry, 48, 6103-6105. (Pubitemid 32056848)
143. Pezet R, Pont V. (1988) Demonstration of pterostilbene in clusters of Vitis vinifera. Plant Physiology and Biochemistry, 26, 603-607.
144. Tolomeo M, Grimaldo S, Di Cristina A, Roberti M, Pizzarani D, Meli M, Dusonchet L, Gebbia N, Abbadessa V, Crosta L, Barucchello R, Grisolia G, Invidiata F, Simoni D. (2005) Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. The International Journal of Biochemistry and Cell Biology, 37, 1709-1726.
145. Ros-Barcelo A, Pomar F, Lopez-Serran, M, Pedreno MA. (2003) Peroxidase: a multifunctional enzyme in grapevines. Functional Plant Biology, 30, 577-591.
146. Oshima Y, Namao K, Kamijou A, Matsuoka S, Nakano M, Terao K, Ohizumi Y. (1995) Powerful hepatoprotective and hepatotoxic plant oligostilbenes, isolated from the Oriental medicinal plant Vitis coígnetíae (Vitaceae). Experiencia, 51, 63-66.
147. Privat C, Telo JP, Bernardes-Genisson V, Vieira A, Souchard JP, Nepveu F. (2002) Antioxidant properties of trans-ε-viniferin as compared to stilbene derivates in aqueous media. Journal of Agricultural and Food Chemistry, 50, 1213-1217. (Pubitemid 34194082)
148. Billiard C, Izard JC, Roman V, Kern C, Mathiot C, Ments F, Kolb JP. (2002) Comparative antiproliferative and apoptotic effects of resveratrol, ε-viniferin and vine-shots derived polyphenols (vineatrols) on chronic B lymphocytic leukaemia cells and normal human lymphocytes. Leukemia & Lymphoma, 43, 1991-2002.
149. Piver B, Berthou F, Dreano Y, Lucas D. (2003) Differential inhibition of human cytochrome P450 enzymes by ε-viniferin, the dimmer of resveratrol: comparison with resveratrol and polyphenols from alcoholised beverages. Life Sciences, 73, 1199-1213. (Pubitemid 36733564)
150. Yañez M, Fraiz N, Cano E, Orallo F. (2006) (-)-Trans-ε- viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake, and of monoamine oxidase activity. European Journal of Pharmacology, 542, 54-60. (Pubitemid 44081986)
151. Douillet-Breuil A, Jeandet P, Adrian M, Bessis R. (1999) Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation. Journal of Agricultural and Food Chemistry, 47, 4456-4461. (Pubitemid 29506267)
152. Rayne S, Karacabey E, Mazza G. (2008) Grape cane waste as a source of trans-viniferin: High value phytochemicals with medicinal and anti-phytopathoenic applications. Industrial Crops and Products, 27, 335-340. (Pubitemid 351381397)
153. Takaya Y, Yan KX, Terashima K, He YH, Niwa M. (2002) Biogenetic reactions on stilbene tetramers from Vitaceaeous plants. Tetrahedron, 58, 9265-9271. (Pubitemid 35284716)
154. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventós RM, Berenguer T, Jakszyn P, Martínez C, Sánchez MJ, Navarro C, Chirlaque MD, Tormo MJ, Quirós JR, Amiano P, Dorronsoro M, Larrañaga N, Barricarte A, Ardanaz E, González CA. (2008) Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort. British Journal of Nutrition, 100, 188-196.
155. Walle T, Hsieh F, DeLegge MH, Oatis JE, Walle UK. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition, 32, 1377-1382.
156. Marier JF, Vachon P, Gritsas A, Zhang J, Moreau JP, Ducharme MP. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. Journal of Pharmacology and Experimental Therapeutics, 302, 369-373.
157. Urpi-Sarda M, Jauregui O, Lamuela-Raventos RM, Jaeger W, Miksits M, Covas MI, Andres-Lacueva C. (2005) Uptake of diet resveratrol into the human low-density lipoprotein. Identification and quantification of resveratrol metabolites by liquid chromatography coupled with tandem mass spectrometry. Analytical Chemistry, 77, 3149-55.
158. Bertelli AAE, Giovannini L, Stradi R, Bertelli A, Tillement JP. (1996) Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reaction, 18, 67-71.
159. Bertelli AAE. (2007) Wine, research and cardiovascular disease: instructions for use. Atherosclerosis, 195, 242-247.
160. Bertelli A, Bertelli AAE, Gozzini A, Giovannini L. (1998) Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs under experimental and clinical research, 24, 133-138.
161. (a) Chen Y, Tseng SH, Lai HS, Chen WJ. (2004) Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery, 136, 57-66;
162. (b) Chillemi R, Sciuto S, Spatafora C, Tringali C. (2007) Anti-tumor properties of stilbene-based resrveratrol analogues: recent results. Natural Product Communications, 2, 499-513.
163. Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A, Latruffe N. (2004) Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochemical Pharmacology, 68, 1113-1118.
164. El-Mohsen MA, Bayele H, Kuhnle G, Gibson G, Debnam E,9 Srai SK; Rice-Evans C, Spencer JPE. (2006) Distribution of [3H]trans-resveratrol in rat tissues following oral administration. British Journal of Nutrition, 96, 62-70.
165. Vitrac X, Desmouliere A, Brouillaud B, Krisa S, Deffieux G, Barthe N, Rosenbaum J, Merillon JM. (2003) Distribution of [14C]-trans-resveratrol, a cancer chemo-preventive polyphenol, in mouse tissues after oral administration. Life Sciences, 72, 2219-2233.
166. De Santi C, Pietrabissa A, Spisni R, Mosca F, Pacifici GM. (2000) Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica, 30, 609-617.
167. Mertens-Talcott SU, Percival SS. (2005) Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Letters, 218, 141-51.
168. Chan MM, Mattiacci JA, Hwang HS, Shah A, Fong D. (2000) Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochemical Pharmacology, 60, 1539-1548.
169. Fang JG, Lu M, Chen ZH, Zhu HH, Li Y, Yang L, Wu LM, Liu ZL. (2002) Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles. Chemistry, 8, 4191-4198.
170. Conte A, Pellegrini S, Tagliazucchi D. (2003) Synergistic protection of PC12 cells from β-amyloid toxicity by resveratrol and catechin. Brain Research Bulletin, 62, 29-38.
171. Heredia A, Davis C, Redfield R. (2000) Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. Journal of Acquired Immune Deficiency Syndromes, 25, 246-255.
172. Vivancos M, Moreno JJ. (2008) Effect of resveratrol, tyrosol and β-sitosterol on oxidized low-density lipoprotein-stimulated oxidative stress, arachidonic acid release and prostaglandin E2 synthesis by RAW 264.7 macrophages. British Journal of Nutrition, 99, 1199-1207.
173. Goldberg DM, Yan J, Soleas GJ. (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry, 36, 79-87.
174. Juan ME, Vinardell MP, Planas JM. (2002) The daily oral administration, of high doses of trans-resveratrol to rats for 28 days is not harmful. Journal of Nutrition, 132, 257-260.
175. Arthur PG, Niu X, Rigby P, Steer JH, Jeffrey GP. (2008) Oxidative stress causes a decline in lysosomal integrity during hypothermic incubation of rat hepatocytes. Free Radical Biology & Medicine, 44, 24-33.
176. Li Y, Cao Z, Zhu H. (2006) Up-regulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacological Research, 53, 6-15.
177. Wenzel E, Soldo T, Erbersdobler H, Somoza V. (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Molecular Nutrition and Food Research, 49, 482-494.
178. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A. (1995) Effect of red wine ingestion on the antioxidant capacity of serum. Clinical Chemistry, 41, 32-35.
179. Holvoet P. (2004) Oxidized LDL and coronary heart disease. Acta Cardiologica, 59, 479-484.
180. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
181. Hao HD, He LR. (2004) Mechanisms of cardiovascular protection by resveratrol. Journal of Medicinal Food, 7, 290-298.
182. Das S, Das DK. (2007) Anti-inflammatory responses of resveratrol. Inflammation & Allergy:Drugs Targets, 6, 168-173.
183. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. (1993) Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet, 341, 454-457.
184. Bertelli AAE, Giovannini L, Giannessi D, Migliori M, Bernini W, Fregoni M, Bertelli A. (1995) Antiplatelet activity of synthetic and natural resveratrol in red wine. International Journal of Tissue Reactions, 17, 1-3.
185. Wang Z, Zou J, Cao K, Hsieh T, Huang Y, Wu JM. (2005) Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. International Journal of Molecular Medicine, 16, 533-540.
186. + current in vascular endothelial cells. Cardiovascular Research, 45, 1035-1045.
187. Orallo F, Alvarez E, Camina M, Leiro JM, Gomez E, Fernandez P. (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Molecular Pharmacology, 61, 294-302.
188. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radical Biology and Medicine, 27, 160-169.
189. Floreani M, Napoli E, Quintieri L, Palatini P. (2003) Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Science, 72, 2741-2750.
190. Aggarwal B, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research, 24, 2783-2840.
191. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N, Raul F. (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutrition and Cancer, 39, 102-107.
192. Garvin S, Ollinger K, Dabrosin C. (2006) Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Letter, 231, 113-122.
193. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. (2007) Resveratrol: A review of preclinical studies for human cancer prevention. Toxicology and Applied Pharmacology, 224, 274-283.
194. Kimura Y, Okuda H. (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice. Journal of Nutrition, 131, 1844-1849.
195. Hecht SS, Kenney PMJ, Wang M, Trushin N, Agarwal S, Venket Rao A, Upadhyaya P. (1999) Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[ a ]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Letters, 137, 123-130.
196. Martinez ME, O'Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, Guo Y, Boorman D, Einspahr J, Alberts DS, Gerner EW. (2003) Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proceedings of the National Academy of Sciences USA, 100, 7859-7864.
197. Schneider Y, Vincent F, Duranton B, Badolo L, Gossé F, Bergmann C, Seiler N, Raul F. (2000) Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Letters, 158, 85-91. (Pubitemid 30627485)
198. Smith-Warner SA, Spiegelman D, Yaun SS, Van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A, Hunter DJ. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. Journal of the American Medical Association, 279, 535-540. (Pubitemid 28113433)
199. Smith-Warner S, Spiegelman D, Adami H-O. (2001) Types of dietary fat and breast cancer: a pooled analysis of cohort studies. International Journal of Cancer, 92, 767-774. (Pubitemid 32385723)
200. Smith-Warner S, Spiegelman D, Yaun SS. (2001) Intake of fruits and vegetables and risk of breast cancer. A pooled analysis of cohort studies. Journal of the American Medical Association, 285, 769-776.
201. Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R. (2003) Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. The FASEB Journal, 17, 2339-2341. (Pubitemid 39561486)
202. Provinciali M, Re F, Donnini A, Orlando F, Bartozzi B, Di Stasio G, Smorlesi A. (2005) Effect of resveratrol on the development of spontaneous mammary tumours in HER-2/neu transgenic mice. International Journal of Cancer, 115, 36-45. (Pubitemid 40559666)
203. Levi F, Pasche C, Lucchini F, Ghidoni R, Ferraroni M, La Vecchia C. (2005) Resveratrol and breast cancer risk. European Journal of Cancer Prevention: the official journal of the European Cancer Prevention Organisation (ECP), 14, 139-142.
204. Mahady GB, Pendland SL. (2000) Resveratrol inhibits the growth of Helicobacter pylori in vitro. American Journal of Gastroenterology, 95, 1849.
205. Riles WL, Erickson J, Nayyar S, Atten MJ, Attar BM, Holian O. (2006) Resveratrol engages selective apoptotic signals in gastric adenocarcinoma cells. World Journal of Gastroenterology, 12, 5628-5634. (Pubitemid 44594036)
206. Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. (2006) Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Molecular Cancer Therapeutics, 5, 1335-1341. (Pubitemid 43881327)
207. Lin HY, Shih A, Davis FB, Tang HY, Martino LJ, Bennett JA, Davis PJ. (2002) Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. The Journal of Urology, 168, 748-755. (Pubitemid 34793357)
208. Sala G, Minutolo F, Macchia M, Sacchi N, Ghidoni R. (2003) Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells. Drugs under Experimental and Clinical Research, 29, 263-269. (Pubitemid 38568633)
209. Wang TTY, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN, Hursting SD. (2008) Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis, 29, 2001-2010.
210. Von Löw EC, Perabo FG, Siener R, Müller SC. (2007) Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo, 21, 189-204.
211. De Vries E, Bray FI, Coebergh JWW, Parkin DM, Jechova M, Storm HH, Quinn M, Aareleid T, Hakulinen T, Schouten L, Andersen A, Zatonski W, Brewster D, Plesko I, Pompe-Kim V, Barlow L, Mace-Lesech J, Arveux P, Faivre J, Raverdy N, Sauvage M, Paci E, De Lisi V, Gafa L, Zenetti R, Berrino F, Garcia CM, Ardanaz E, Borras J, Torhorst J, Bouchardy C, Levi FG, Fisch T, Schueler G. (2003) Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: Rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. International Journal of Cancer, 107, 119-126.
212. Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. (2003) Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Letters, 190, 157-163. (Pubitemid 36136014)
213. Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB Journal, 19, 1193-1195. (Pubitemid 40946462)
214. Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y, Kaganoi J, Hashimoto Y, Imamura M. (2002) Suppression of nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis, 23, 1531-1536. (Pubitemid 35012434)
215. Zhou HB, Yan Y, Sun YN, Zhu JR. (2003) Resveratrol induces apoptosis in human oesophageal carcinoma cells. World Journal of Gastroenterology, 9, 408-411. (Pubitemid 36372096)
216. Shih A, Davis FB, Lin HY, Davis PJ. (2002) Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. Journal of Clinical Endocrinology Metabolism, 87, 1223-1232. (Pubitemid 36121092)
217. Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, Reber HA, Pandol SJ. (2002) Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. International Journal of Cancer, 98, 761-769. (Pubitemid 34225629)
218. Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T, Hirose M. (2006) Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Letters, 241, 275-280. (Pubitemid 44163037)
219. Cao Z, Fang J, Xia C, Shi X, Jiang BH. (2004) trans-3,4,5′- trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clinical Cancer Research, 10, 5253-5263. (Pubitemid 39099800)
220. Durrant D, Richards JE, Walker WT, Baker KA, Simoni, D, Lee RM. (2008) Mechanism of cell death induced by cis-3,4 ′,5- trimethoxy-3 ′-aminostilbene in ovarian cancer. Gynecologic Oncology, 110, 110-117.
221. Michels G, Watjen W, Weber N, Niering P, Chovolou Y, Kampkoetter A, Proksch P, Kahl R. (2006) Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells. Toxicology, 225, 173-182. (Pubitemid 44108376)
222. Miura D, Miura Y, Yagasaki K. (2003) Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sciences, 73, 1393-1400. (Pubitemid 36798126)
223. Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL, Pan CE. (2004) Effect of resveratrol and in combination with 5-FU on murine liver cancer. World Journal of Gastroenterology, 10, 3048-3052.
224. Athar M, An KP, Morel KD, Kim AL, Aszterbaum M, Longley J, Epstein EH Jr, Bickers DR. (2001) Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. Biochemical and Biophysical Research Communications, 280, 1042-1047.
225. Horvath Z, Saiko P, Illmer C, Madlener S, Hoechtl T, Bauer W, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T. (2005) Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukaemia cells. Experimental Hematology, 33, 329-335.
226. Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SC. (2002) Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. Journal of Nutrition, 132, 2076-2081.
227. Gehm BD, McAndrews JM, Chien PY, Jameson JL. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proceedings of the National Academy of Sciences of U.S.A., 94, 14138-14143.
228. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS. (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. Journal of Biological Chemistry, 280, 7460-7468.
229. King RE, Bomser JA, Min DB. (2006) Bioactivity of resveratrol. Comprehensive Reviews in Food Science and Food Safety, 5, 65-70.
230. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM. (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Research, 61, 7456-7463.
231. Basly JP, Marre-Fournier F, Le Bail JC, Habrioux G, Chulia AJ. (2000) Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Science, 66, 769-777.
232. Chen G, Shan W, Wu Y, Ren L, Dong J, Ji Z. (2005) Synthesis and anti-inflammatory activity of resveratrol analogs. Chemical and Pharmaceutical Bulletin, 53, 1587-1590.
233. Rahman I, Biswas SK, Kirkham PA. (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochememical Pharmacology, 72, 1439-1452. (Pubitemid 44666744)
234. Sinclair D. (2005) Sirtuins for healthy neurons. Nature Genetics, 37, 339-340.
235. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C. (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Natature Genetics, 37, 349-350.
236. Karlsson J, Emgard M, Brundin P, Burkitt MJ. (2000) Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. Journal of Neurochemistry, 75, 141-150.
237. Dong W, Li N, Gao D, Zhen H, Zhang X, Li F. (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. Journal of Vascular Surgery, 48, 709-714.
238. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430, 686-689.
239. Harikumar KB, Aggarwal BB. (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle, 7, 1020-1035.
240. Szkudelski T. (2008) The insulin-suppressive effect of resveratrol: an in vitro and in vivo phenomenon. Life Science, 82, 430-435.